Levothyroxine Sodium Tablets6505-01-287-0622

NSN 6505-01-287-0622 · NIIN 012870622

FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment

Government record, cited

Also searched as 6505-01-287-0622 · 6505012870622 · NIIN 012870622 · 01-287-0622 · FSC 6505 Drugs and Biologicals · NDC00536-4380-10 · NDC00536-3953-10 · 0039530

Nearby stock numbers ← 6505-01-287-0621 Barium Sulfate for Suspension, Modified · 6505-01-287-0623 →

Features

Levothyroxine Sodium Tablets — FSC 6505
Primary Container Content Quantity: 1000.000 TABLETS
Medical Designation and Grade: UNITED STATES PHARMACOPEIA
Primary Container Type: BOTTLE
Active Medicament Medicinal Strength: 0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT

Identification

NSN: 6505-01-287-0622
NIIN: 012870622
FSC: 6505 — Drugs and Biologicals
FSG: 65 — Medical, Dental, and Veterinary Equipment

General Description

The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-287-0622, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.

Technical Specifications

Parameter	Value
NSN	6505-01-287-0622
Item Name	Levothyroxine Sodium Tablets
FSC / FSG	6505 / 65 — Drugs and Biologicals
Status	ACTIVE
Primary Container Content Quantity	1000.000 TABLETS
Medical Designation and Grade	UNITED STATES PHARMACOPEIA
Primary Container Type	BOTTLE
Active Medicament Medicinal Strength	0.150 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT

Lifecycle & Compliance

Acquisition Status	ACTIVE
DEMIL Code	DEMIL A — No Demilitarization Required
Hazard	Possible hazard — SDS may be required (DLA HMIC P)
Criticality Code	X

Cross-Reference Index

No manufacturer part numbers on file in the U.S. Government catalog.

Reference documents

Reference	Meaning
NDC00536-4380-10	3/9 Design control — primary reference Rugby Group Inc
NDC00536-3953-10	5/9 Secondary reference Rugby Group Inc
0039530	5/9 Secondary reference Rugby Group Inc

No interchangeability data on file.

Other items in FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073

6505-00-000-0073 · Item name not on file

6505-00-000-0110

6505-00-000-0110 · Item name not on file

6505-00-000-0134

6505-00-000-0134 · Item name not on file

6505-00-000-0135

6505-00-000-0135 · Item name not on file

6505-00-001-3344

6505-00-001-3344 · Item name not on file

6505-00-001-3345

FLUORESCEIN SODIUM AND BENOXINAT

6505-00-001-3346

6505-00-001-3346 · Item name not on file

6505-00-001-3347

6505-00-001-3347 · Item name not on file

Frequently Asked Questions

What is NSN 6505-01-287-0622?

NSN 6505-01-287-0622 is a Levothyroxine Sodium Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-287-0622?

Key specifications for 6505-01-287-0622: Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: MEDSEP ITEM FOR DOD,RUGBY LABS. 4 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-287-0622 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.

PartsTable Design LLC · partstable.com